[Asia Economy Reporter Ji Yeon-jin] Youngjin Pharmaceutical announced on the 10th that its sales in the first quarter of this year reached 52.3 billion KRW, an increase of 19.9% compared to the same period last year.



During this period, operating loss decreased by 59.6% to approximately 700 million KRW, and net loss also declined by 18.1% to 1.4 billion KRW.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing